Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-11-13

Clinical Trial Update: Aspirin (ASA) Therapy and Preeclampsia Prevention [Phase 4]

View source ↗

Summary

A Phase 4 trial studying aspirin therapy for preeclampsia prevention has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Tennessee | Conditions: Preeclampsia | Phase 4 | Status: WITHDRAWN